Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
38.21
-0.17 (-0.44%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,354,100
Open
38.11
Bid (Size)
37.72 (1)
Ask (Size)
38.48 (2)
Prev. Close
38.38
Today's Range
37.80 - 38.32
52wk Range
33.67 - 45.92
Shares Outstanding
5,385,189,617
Dividend Yield
3.78%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
July 02, 2024
A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
June 27, 2024
The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further...
Via
Benzinga
Performance
YTD
+1.87%
+1.87%
1 Month
-6.53%
-6.53%
3 Month
-8.57%
-8.57%
6 Month
+1.87%
+1.87%
1 Year
+8.27%
+8.27%
More News
Read More
Why Is Moderna Stock Trading Lower On Wednesday?
June 26, 2024
Via
Benzinga
Exposures
COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
June 26, 2024
Via
Investor's Business Daily
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Via
Benzinga
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
June 24, 2024
Via
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
June 18, 2024
Via
Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Via
InvestorPlace
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Via
InvestorPlace
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
Via
Investor's Business Daily
Exposures
COVID-19
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
June 07, 2024
From
GSK plc
Via
Business Wire
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Large Cap BIopharmaceuticals Overview
June 03, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
June 03, 2024
Via
InvestorPlace
Topics
Lawsuit
Exposures
Financial
Legal
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
June 03, 2024
Via
Benzinga
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
June 03, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
June 03, 2024
From
GSK plc
Via
Business Wire
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
Via
The Motley Fool
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 03, 2024
Via
Benzinga
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
June 02, 2024
From
GSK plc
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.